Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1

Interventions

Dexamethasone 70Lenalidomide 39daratumumab 37Bortezomib 33pomalidomide 31Specimen Handling 28Biopsy 26carfilzomib 24Cyclophosphamide 24Calcium Dobesilate 24Magnetic Resonance Spectroscopy 21dexamethasone acetate 16dexamethasone 21-phosphate 16auricularum 16isatuximab 14fludarabine 13belantamab mafodotin 12iberdomide 11Melphalan 11talquetamab 10selinexor 9X-Rays 8tocilizumab 7fludarabine phosphate 7elotuzumab 6Nuclear Medicine Department, Hospital 5trametinib 4pembrolizumab 4nirogacestat 4Thalidomide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mental Status and Dementia Tests × Plasma cell × 30 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡